Skip to main content
2024 AATOD Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Evaluation ViewAttendees 16

Pre-Conference Session

Patient Care & Best Practices

PC16 - Buprenorphine in the Age of Fentanyl

Sunday, May 19, 2024
2:00 PM – 4:00 PM PST
Location: Sunset 2
CE: 2.0
Presentation Summary: Fentanyl use is by far the largest killer in the U.S opioid epidemic today. While buprenorphine formulations are the most utilized medication for opioid use disorder (MOUD), unique aspects of fentanyl pharmacology pose challenges for buprenorphine initiation and maintenance. We describe various induction strategies to transition those physiologically dependent on fentanyl onto buprenorphine, both oral and injectable formulations. Common problems encountered in such inductions will be discussed.

Learning Objectives:

At the completion of this activity, participants will:
  • Explain the pharmacology of fentanyl and how this may impact induction onto buprenorphine formulations.
  • Identify common problems encountered in induction of one who is physiologically dependent on fentanyl onto buprenorphine formulations.
  • Describe sublingual/buccal and injectable buprenorphine induction strategies modified for those physiologically dependent on fentanyl.